Navigation Links
The Journal of Clinical Oncology Publishes Phase 3 XGEVA™ (Denosumab) Results in Advanced Cancer Patients With Solid Tumors or Multiple Myeloma
Date:2/22/2011

invalidated or circumvented by our competitors and there can be no guarantee of our ability to obtain or maintain patent protection for our products or product candidates. We cannot guarantee that we will be able to produce commercially successful products or maintain the commercial success of our existing products. Our stock price may be affected by actual or perceived market opportunity, competitive position, and success or failure of our products or product candidates. Further, the discovery of significant problems with a product similar to one of our products that implicate an entire class of products could have a material adverse effect on sales of the affected products and on our business and results of operations.

The scientific information discussed in this news release relating to new indications for our products is preliminary and investigative and is not part of the labeling approved by the U.S. Food and Drug Administration (FDA) for the products. The products are not approved for the investigational use(s) discussed in this news release, and no conclusions can or should be drawn regarding the safety or effectiveness of the products for these uses. Only the FDA can determine whether the products are safe and effective for these uses. Healthcare professionals should refer to and rely upon the FDA-approved labeling for the products, and not the information discussed in this news release. CONTACT: Amgen, Thousand OaksChristine Regan: +1 (805) 447-5476 (media)Lisa Rooney: +1 (805) 447-6437 (media)Arvind Sood: +1 (805) 447-1060 (investors)(i)  Coleman RE. Skeletal complications of malignancy. Cancer. 1997; 80(suppl): 1588-1594.

(ii)  Lipton A, Theriault RL, Hortobagyi GN. Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases. Cancer 2000;88:1082-1090.

(iii)  Saad F, Lipton A, Cook R, Chen YM, Smith M, Coleman R. Pathologic fractures co
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
2. Adlyfe Study on the Detection of Misfolded Proteins Published in the Journal Transfusion
3. Nebivolol Lowers Blood Pressure in Mild-to-Moderate Hypertensive Patients as Demonstrated in a Study Published in the Journal of Clinical Hypertension
4. Results from Study Evaluating PROCRIT(R) in Intensive Care Unit Patients Published in New England Journal of Medicine
5. Hypertension: Journal of the American Heart Association Rapid Access Reports: Hispanics Hypertension Better Controlled With Equal Access to Care
6. Vaccine Study in New England Journal of Medicine Wrong in Concluding Mercury Exposures are Harmless, States SafeMinds
7. Risks Associated With Face Transplants May Be Lower Than Previously Thought, ASPS Journal Review Suggests
8. Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine
9. Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension
10. UPDATE: Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension
11. The New England Journal of Medicine Publishes First Clinical Results for MedImmunes Chitinase-like Protein YKL-40 in Patients With Asthma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... , May 4, 2015 RadiologyAuction will have their ... video and product demonstrations at the end of the ... such as Kodak and Fuji Cr,s, Agfa and Sony, ... the first event. Various imaging equipment will be available ... After years of buying and selling imaging ...
(Date:5/4/2015)... May 4, 2015  Oncobiologics, Inc., a biotherapeutics ... (mAb) biosimilars, has completed the construction of its ... in Cranbury, New Jersey . ... facility is designed to utilize multiple technologies that ... scale.  Through the use of the latest single-use ...
(Date:5/4/2015)... Calif. , May 4, 2015  Isis Pharmaceuticals, ... exclusive license agreement with Bayer HealthCare (Bayer) to develop ... thrombosis. Under the terms of the agreement, Isis is ... payments, including an immediate $100 million up-front payment and ... following a Phase 2 study in patients with compromised ...
Breaking Medicine Technology:RadiologyAuction Announces Event Starting On May 5th 2Oncobiologics opens commercial launch manufacturing facility in Cranbury, New Jersey 2Oncobiologics opens commercial launch manufacturing facility in Cranbury, New Jersey 3Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 2Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 3Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 4Isis Pharmaceuticals Licenses ISIS-FXI Rx to Bayer to Develop and Commercialize for the Prevention of Thrombosis 5
(Date:5/4/2015)... Each year, the Susan G. Komen organization ... awareness for breast cancer. This year, Dr. Mark Deutsch and ... the entertainment sponsor for the 25th annual Susan G. Komen ... the Lenox Square Mall. , The Komen organization hopes have ... $1.2 million. Perimeter Plastic Surgery has not only taken on ...
(Date:5/4/2015)... (PRWEB) May 04, 2015 Getting patients ... manage their health is critical to achieving the “triple ... reducing costs, but this will require a shift in ... also demands that health systems move beyond their traditional ... took part in the third live meeting of the ...
(Date:5/4/2015)... (PRWEB) May 04, 2015 “ LiveSchool ... monthly AppWatch, which takes a look at the latest ... and Windows. Joe Toohey, the host of AppWatch and ... viewers how this application allows teachers to reward students ... than some realize, especially in the classroom. And ...
(Date:5/4/2015)... The Lymphoma Research Foundation (LRF) – the ... lymphoma research and serving the lymphoma community through a ... services – is set to host its annual Ace ... Orange, NJ on June 1, 2015. Since 2010, the ... through LRF. , This year, the Lymphoma Research Foundation ...
(Date:5/4/2015)... The opportunity for children to dream of ... motivating forces behind The Fairy Godmother Next Door, a new ... L. Stark. , The inspiration for the enchanting story of ... from Stark’s desire to be a fairy godmother. , “My ... to my neighbors’ children since they were born. We discuss ...
Breaking Medicine News(10 mins):Health News:Perimeter Plastic Surgery Sponsors 2015 Susan G. Komen Greater Atlanta "Race for the Cure" 2Health News:AJMC’s ACO Coalition Explores the New Rules of Patient Engagement 2Health News:AJMC’s ACO Coalition Explores the New Rules of Patient Engagement 3Health News:AJMC’s ACO Coalition Explores the New Rules of Patient Engagement 4Health News:An Application for Teachers to Reward Students with Good Behavior Was Featured on NewsWatch Television 2Health News:Lymphoma Research Foundation Set to Host Annual Ace Lymphoma Luncheon at Mayfair Farms in West Orange, NJ 2Health News:Introducing New Children’s Book The Fairy Godmother Next Door 2
... 8, 2007 -- Results from two investigational Phase I ... preliminary anti-tumor activity in patients with relapsed and/or refractory ... 10 of 21 (48 percent) evaluable patients had a ... combination treatment. Data from a second study, sponsored ...
... Boca Raton, FL, December 8, 2007 Researchers may ... almost immediately by directly targeting novel molecules in the ... can lead to longer times for medication to take ... American College of Neuropsychopharmacology (ACNP) annual meeting. The antidepressant ...
... Elderly may be especially prone to depression this time of ... For some older people, the holidays can generate feelings of ... or health problems, experts note. , To help seniors ... offers the following tips: , Socialize. Ask family and ...
... CV Therapeutics,Inc. (Nasdaq: CVTX ) announced today that ... Company that it will evaluate the,approval of potential anti-arrhythmic ... ongoing review of the Company,s,supplemental new drug application (sNDA)., ... seeking expansion to the,approved product labeling for Ranexa to ...
... Legendary blues artists Bobby,Rush and James "Super Chikan" Johnson ... Blues Marathon and Half-Marathon on Saturday,January 5, 2008. The ... at 200,South Commerce Street, in downtown Jackson. Doors will ... on stage at 8:00 p.m., and the Bobby Rush,Revue ...
... Ala., Dec. 7 BioHorizons Implant Systems,Inc. ... to a,state-of-the- art, 44,000 square foot facility. ... houses all administrative services, a newly,formed manufacturing ... will include machining, surface treatment and packaging ...
Cached Medicine News:Health News:ZOLINZA (vorinostat) in combination with bortezomib demonstrated clinical activity 2Health News:ZOLINZA (vorinostat) in combination with bortezomib demonstrated clinical activity 3Health News:Study shows new strategy for developing antidepressants 2Health News:Study shows new strategy for developing antidepressants 3Health News:How to Spot, and Beat, the Holiday Blues 2Health News:FDA Reviewing Potential Anti-Arrhythmic Claims for Ranexa(R) 2Health News:FDA Reviewing Potential Anti-Arrhythmic Claims for Ranexa(R) 3Health News:BioHorizons Expands to New 44,000 Square Foot Facility 2
... acuity system allows you access to the ... The system includes 10 different optotypes, crowding ... animated characters. Random character sequencing eliminates memorization. ... single line and multiple line selection capability. ...
... Light Probes provide the surgeon with an ... interface to be easily visualized through the ... effect and light scatter technique, the surgeon ... deposits, flap edge folds, corneal flap striae ...
... visual acuity system allows you access to ... II. The system includes 10 different optotypes, ... and animated characters. Random character sequencing eliminates ... letter, single line and multiple line selection ...
... to 64 channel sleep diagnostic collection software. ... 64 channel sleep diagnostic collection software offers ... recording or post recording. The scoring displays ... sleep events including current number of events, ...
Medicine Products: